Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia, Ruhr University Bochum, Bad Oeynhausen, Germany.
J Am Coll Cardiol. 2013 Apr 23;61(16):1707-12. doi: 10.1016/j.jacc.2012.09.033. Epub 2012 Nov 28.
The purpose of this study was to investigate long-term outcomes of freedom from atrial fibrillation (AF) after pulmonary vein (PV) isolation using cryoballoon ablation with balloon-size selection based on individual PV diameters.
Data are lacking on long-term outcomes from cryoablation and on the most effective balloon size.
This was a prospective observational study involving 605 consecutively enrolled patients with symptomatic paroxysmal AF (n = 579) or persistent AF. Cryoballoon size was based on magnetic resonance imaging and/or conventional angiograms. Patients were followed up every 3 months during the first year after discharge and every 6 months in the second year. After 24 months, follow-up was on an outpatient basis with documented AF episodes recorded.
The PV isolation was achieved without touch-up in 91.1% of patients, using the smaller balloon in 26.7%, the larger balloon in 25.6%, and both balloons in 47.7% of patients. Follow-up data for >12 months (median 30 months; interquartile range 18 to 48 months) were available for 451 patients, 278 (61.6%) of whom were free of AF recurrence with no need for repeat procedures after the 3-month blanking period. Rates of freedom from AF after 1, 2, and 3 repeat procedures (using cryoballoon or radiofrequency ablation with similar success rates) were 74.9%, 76.2%, and 76.9%, respectively. Use of the smaller balloons or both balloons produced the highest rates of long-term freedom from AF. Phrenic nerve palsy occurred in 12 patients (2%), resolving within 3 to 9 months.
Rates of long-term freedom from AF after cryoballoon ablation are similar to those reported for radiofrequency ablation. A choice between balloons may improve outcomes.
本研究旨在探讨基于个体肺静脉(PV)直径选择球囊大小行冷冻球囊消融(CAB)后 PV 隔离患者的长期无房颤(AF)结局。
关于冷冻消融的长期结果和最有效的球囊大小的数据尚缺乏。
这是一项前瞻性观察研究,纳入了 605 例连续入组的症状性阵发性 AF(n=579)或持续性 AF 患者。CAB 时根据 MRI 和/或常规血管造影选择球囊大小。患者在出院后 1 年内每 3 个月、第 2 年每 6 个月随访 1 次,24 个月后进行门诊随访,记录有症状的 AF 发作。
91.1%的患者实现了无补点的 PV 隔离,其中 26.7%的患者使用小一号球囊,25.6%的患者使用大一号球囊,47.7%的患者使用了两个球囊。451 例患者(278 例[61.6%])的随访时间超过 12 个月(中位数为 30 个月;四分位距为 18 至 48 个月),且在 3 个月空白期后无需重复操作,无 AF 复发。重复 CAB 或射频消融(成功率相似) 1、2 和 3 次后无 AF 发生率分别为 74.9%、76.2%和 76.9%。使用小一号球囊或两个球囊可获得最高的长期无 AF 发生率。膈神经麻痹在 12 例患者(2%)中发生,在 3 至 9 个月内缓解。
CAB 后长期无 AF 发生率与射频消融报告的结果相似。球囊的选择可能改善结局。